Outside Biogen's headquarters in Cambridge, MA (Steven Senne/AP Images)
How cozy is too cozy? FDA and Biogen offer up a test case
As the saga over how to pay for Aduhelm plays out, biopharma companies are now looking closely at how Biogen was able to keep such …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
